IL72227A - Pharmaceutical compositions containing 2-pentanoylaminoacetic acid or a salt thereof - Google Patents

Pharmaceutical compositions containing 2-pentanoylaminoacetic acid or a salt thereof

Info

Publication number
IL72227A
IL72227A IL72227A IL7222784A IL72227A IL 72227 A IL72227 A IL 72227A IL 72227 A IL72227 A IL 72227A IL 7222784 A IL7222784 A IL 7222784A IL 72227 A IL72227 A IL 72227A
Authority
IL
Israel
Prior art keywords
pentanoylaminoacetic
salt
acid
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL72227A
Other languages
English (en)
Other versions
IL72227A0 (en
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Continental Pharma filed Critical Continental Pharma
Publication of IL72227A0 publication Critical patent/IL72227A0/xx
Publication of IL72227A publication Critical patent/IL72227A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL72227A 1983-06-30 1984-06-26 Pharmaceutical compositions containing 2-pentanoylaminoacetic acid or a salt thereof IL72227A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU84891A LU84891A1 (fr) 1983-06-30 1983-06-30 Derives de l'acide 2-aminoacetique,leur preparation et utilisation ainsi que compositions pharmaceutiques contenant ces derives

Publications (2)

Publication Number Publication Date
IL72227A0 IL72227A0 (en) 1984-10-31
IL72227A true IL72227A (en) 1988-08-31

Family

ID=19730112

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72227A IL72227A (en) 1983-06-30 1984-06-26 Pharmaceutical compositions containing 2-pentanoylaminoacetic acid or a salt thereof

Country Status (9)

Country Link
US (1) US4562205A (xx)
EP (1) EP0130644B1 (xx)
JP (1) JPS6036412A (xx)
AU (1) AU563134B2 (xx)
DE (1) DE3474912D1 (xx)
DK (1) DK323284A (xx)
IL (1) IL72227A (xx)
LU (1) LU84891A1 (xx)
ZA (1) ZA844971B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0575613B1 (de) * 1992-01-10 1998-07-22 KOMISSAROVA, Irina Alexeevna Verwendung der aminosäure glycin zur herstellung von arzneimitteln mit antistress-, stressschutz- und nootroper wirkung
EP1604654A1 (en) * 2004-05-18 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating dyskinesia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2145402A1 (en) * 1971-07-13 1973-02-23 Allard Andre Magnesium acetylglycinate hexahydrate - for treating hypomagnesaemia
RO68298A2 (ro) * 1975-08-05 1980-04-15 Intreprinderea De Medicamente,Ro Compozitie pe baza de saruri organice de calciu si magneziu usor asimilabile si cu o solubilitate crescuta,si procedeu de preparare a acesteia
FR2422400A1 (fr) * 1978-04-13 1979-11-09 Morelle Jean Nouvelles compositions destinees a l'elimination de certains parasites humains, a base de lipoaminoacides, caracterises par des chaines grasses comportant de 6 a 12 atomes de carbone
US4397866A (en) * 1979-05-07 1983-08-09 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord
US4372974A (en) * 1980-06-25 1983-02-08 New York University Anticonvulsive compositions and method of treating convulsive disorders

Also Published As

Publication number Publication date
US4562205A (en) 1985-12-31
DK323284D0 (da) 1984-06-29
EP0130644B1 (en) 1988-11-02
AU563134B2 (en) 1987-06-25
AU2989684A (en) 1985-01-03
ZA844971B (en) 1985-02-27
DK323284A (da) 1984-12-31
DE3474912D1 (en) 1988-12-08
EP0130644A1 (en) 1985-01-09
IL72227A0 (en) 1984-10-31
JPS6036412A (ja) 1985-02-25
LU84891A1 (fr) 1985-03-29
JPH0137373B2 (xx) 1989-08-07

Similar Documents

Publication Publication Date Title
PH21506A (en) New pharmaceutical composition based on valporic acid
MTP943B (en) Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it
GB2136807B (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
SG93290G (en) Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives
GB8313217D0 (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
CY1678A (en) Pharmaceutical compositions
GB2144630B (en) Pharmaceutical composition containing chitosan
PH25430A (en) Pharmaceutical compositions containing calcium salts
GB2136806B (en) Pharmaceutical compositions
IL84845A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
CY1503A (en) Pharmaceutical compositions
IL65170A0 (en) Pharmaceutical compositions containing tetrahydropyridine derivatives or salts thereof
GB2120938B (en) Anti-ulcer pharmaceutical compositions containing salicylic acid or its salts
GB2127406B (en) Piperidinlycyclopentanolheptenoic acid salt
EP0136006A3 (en) Pharmaceutical compositions
GB2110930B (en) Pharmaceutical compositions containing propionhydroxamic acid
DE3472062D1 (en) Pharmaceutical compositions containing epinine or a pharmaceutically acceptable salt thereof
IL72227A (en) Pharmaceutical compositions containing 2-pentanoylaminoacetic acid or a salt thereof
GB2110536B (en) Pharmaceutical compositions containing pantetheine-s-sulphonic acid
GB2126083B (en) Cosmetic comprising pantetheine-s-sulphonic acid or a salt thereof
GB8300767D0 (en) Pharmaceutical compositions
GB8305697D0 (en) Pharmaceutical compositions